Live Breaking News & Updates on திரையிடல் இல் சரியான அறிவியல்
Stay updated with breaking news from திரையிடல் இல் சரியான அறிவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting Age for Colorectal Cancer Screening to 45 National Task Force supports Cologuard® as a screening option and screening expands to an additional ˜19 million Americans News provided by Share this article Share this article MADISON, Wis., May 18, 2021 /PRNewswire/ The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendation that screening begin at age 45. Exact Sciences (NASDAQ: EXAS) Cologuard ®, referred to as sDNA-FIT, is included as a recommended screening option for all average-risk patients between the ages of 45 and 75. Colorectal cancer is the second leading cause of cancer death in the United States, in part because many cancers go undetected until later stages when treatment options are limited. ....
Message : Required fields Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting Age for Colorectal Cancer Screening to 45 National Task Force supports Cologuard ® as a screening option and screening expands to an additional ˜19 million Americans MADISON, Wis.- May 18, 2021 - The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendationthat screening begin at age 45. Exact Sciences (NASDAQ: EXAS) Cologuard ®, referred to as sDNA-FIT, is included as a recommended screening option for all average-risk patients between the ages of 45 and 75. Colorectal cancer is the second leading cause of cancer death in the United States, in part because many cancers go undetected until later stages when treatment options are limited. ....
Mayo Clinic Proceedings showing that Cologuard (mt-sDNA) is the most cost-effective colorectal cancer (CRC) screening option in the Alaska Native population, as compared to colonoscopy and the fecal immunochemical test (FIT), for a wide range of adherence scenarios. According to the model, Cologuard produced the highest number of quality adjusted life years (QALYs) gained and the largest reduction in CRC incidence. 1 Colorectal cancer is the second leading cause of cancer death for men and women in the United States, 2 in part because many cancers go undetected until later stages when treatment is less effective. 3 Alaska Native (AN) people have among the nation s highest reported incidence rates for CRC, at 89.0 per 100,000 people compared to 45.7 per 100,000 people for the entire United States. ....
Share this article Share this article MADISON, Wis., Jan. 12, 2021 /PRNewswire/ Exact Sciences Corp. (Nasdaq: EXAS) announced data published today in Cancer Prevention Research, a Journal of the American Association for Cancer Research, that expands on foundational clinical study findings to include a key younger population. Study results show that among average-risk adults between the ages of 45 and 49 Cologuard® (mt-sDNA) demonstrated test specificity of 95.2% in participants with non-advanced precancerous lesions or negative findings at colonoscopy and 96.3% in only those with negative colonoscopy findings. These analyses support potential risk mitigation and cost prevention due to unnecessary diagnostic procedures when using Cologuard as a colorectal cancer screening tool in this younger population. ....